Back to 
Arrowstreet Capital, Limited Partnership
Arrowstreet Capital, Limited Partnership
XERS
3 quarters
Position history for Arrowstreet Capital, Limited Partnership's holdings in Xeris Biopharma Holdings, Inc.
Yes. Arrowstreet Capital holds 972,880 shares of XERS, worth $7.7M, as of its Q2 2026 13F filing. It increased the position from 133,760 shares in Q1 2026. Arrowstreet Capital has held XERS since Q4 2025, across 3 quarterly 13F filings.
Current Value
$7.7M
Current Shares
972,880
Total Value Change
+$6M
Total Shares Change
+758,094
Quarter-by-Quarter History
Other major holders of XERS: BlackRock, Inc., Vanguard Group Inc.